BIOMAT Database Logo BIOMAT Database Logo

[Clinical experience with N,N'-dimethyl-N,N'-bis-(3-(3',4',5'-trimethoxybenzoyloxy)-propyl)-ethylenediamine dihydrochloride (hexobendine)]. 1968

W Zimmermann

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D001775 Blood Circulation The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005029 Ethylenediamines Derivatives of ethylenediamine (the structural formula NH2CH2CH2NH2).
D005260 Female Females

Related Publications

W Zimmermann
[STUDIES ON THE RESORPTION, DISTRIBUTION AND ELIMINATION OF N,N'-DIMETHYL-N,N'-BIS(3-(3',4',5'-TRIMETHOXYBENZOXY)PROPYL)-ETHYLENEDIAMINE DIHYDROCHLORIDE].
October 1964, Arzneimittel-Forschung,
W Zimmermann
Lack of teratogenic and embryotoxic properties of (2S, 2'S) N,N'-dimethyl-N,N'-bis [1-(3', 4', 5'-trimethoxybenzoyloxy)-butyl-2] ethylenediamine dihydrochloride (M-71).
January 1980, Polish journal of pharmacology and pharmacy,
W Zimmermann
[ON THE EFFECTS OF N,N'-DIMETHYL-N,N'-BIS-(3-(3',4',5'-TRIMETHOXYBENZOXY)-PROPYL)-ETHYLENEDIAMINE DIHYDROCHLORIDE ON ISOLATED PERFUSED HEARTS OF WARM BLOODED ANIMALS].
October 1964, Arzneimittel-Forschung,
W Zimmermann
[TREATMENT OF CORONARY INSUFFICIENCY WITH N,N'-DIMETHYL-N,N'-BIS-(3-(3',4',5'-TRIMETHOXYBENZOXY)-PROPYL)-ETHLENEDIAMINE-DIHYDROCHLORIDE (ST 7090, USTIMON)].
April 1965, Wiener klinische Wochenschrift,
W Zimmermann
[ON THE EFFECT OF N,N'-DIMETHYL-N,N'-BIS-(3-(3',4',5'-TRIMETHOXYBENZOXY)-PROPYL)-ETHYLENEDIAMINE (USTIMON) IN ANGINA PECTORIS].
April 1965, Wiener klinische Wochenschrift,
W Zimmermann
In vitro study of (2S, 2'S) N,N'-dimethyl-N, N'-bis [1(3', 4', 5'-trimethoxybenzoyloxy) butyl-2] ethylenediamine salts and their bioavailability.
January 1980, Polish journal of pharmacology and pharmacy,
W Zimmermann
[BLOOD COAGULATION AND FIBRINOLYSIS DURING ORAL AND PARENTERAL MEDICATION OF N,N'-DIMETHYL-N,N'-BIS-(3-(3',4',5'-TRIMETHOXYBENZOXY)-PROPYL)-ETHYLENEDIAMINE DIHYDROCHLORIDE IN HUMANS WITH NORMAL BLOOD COAGULATION AND ON SUSTAINED ANTICOAGULANT THERAPY].
October 1964, Arzneimittel-Forschung,
W Zimmermann
[Pharmacobiochemistry of the coronary agent N,N'-bis(3-(3',4',5'-trimethoxy-benzoyloxy)-propyl)-homopiperazine(dihydrochloride-monohydrate)].
September 1972, Arzneimittel-Forschung,
W Zimmermann
[STUDIES ON THE ANTIFIBRILLATORY EFFECT OF N,N'-DIMETHYL- AND N,N'-DIETHYL-N,N'-BIS-(3-(3,4,5-TRIMETHOXYBENZOXY)-PROPYL)-ETHYLENEDIAMINE].
February 1965, Arzneimittel-Forschung,
W Zimmermann
[THE EFFECTS OF N,N'-DIMETHYL-N,N'-BIS-(3-(3',4',5'-TRIMETHOXYBENZOXY)-PROPYL)-ETHYLENEDIAMINE ON THE HEART AND CIRCULATORY DYNAMICS AS WELL AS O-2 SUPPLY TO THE MYOCARDIUM AND BRAIN].
October 1964, Arzneimittel-Forschung,
Copied contents to your clipboard!